1. |
张杰. R语言数据可视化之美. 北京: 电子工业出版社, 2019.
|
2. |
Hehman E, Xie SY. Doing better data visualization. Adv Methods Pract Psychol Sci. 2021, 4(4): 1-18.
|
3. |
Vandemeulebroecke M, Baillie M, Margolskee A, et al. Effective visual communication for the quantitative scientist. CPT Pharmacometrics Syst Pharmacol, 2019, 8(10): 705-719.
|
4. |
Gatto NM, Wang SV, Murk W, et al. Visualizations throughout pharmacoepidemiology study planning, implementation, and reporting. Pharmacoepidemiol Drug Saf, 2022, 31(11): 1140-1152.
|
5. |
林云志, 张隆垚, 陈峰, 等. 医学研究中的统计图形规范. 中华流行病学杂志, 2022, 43(10): 1666-1670.
|
6. |
Gelman A, Vehtari A. What are the most important statistical ideas of the past 50 years? J Am Stat Assoc, 2021: 1-29.
|
7. |
Carmeli AB, Meloney L, Bierer BE. Data visualization explorer: a tool for participant representation in pivotal trials of FDA-approved medicinal products. Patterns (N Y), 2023, 4(5): 100713.
|
8. |
O'Donoghue SI, Baldi BF, Clark SJ, et al. Visualization of biomedical data. Ann Rev of Biomedi Data Sci, 2018, 1(1): 275-304.
|
9. |
卢存存, 陈子佳, 张强, 等. 基于真实世界数据的目标试验模拟研究: 现状与展望. 中国循证医学杂志, 2023, 23(4): 492-496.
|
10. |
Chapman SJ, Aldaffaa M, Downey CL, et al. Research waste in surgical randomized controlled trials. Br J Surg, 2019, 106(11): 1464-1471.
|
11. |
Glasziou P, Altman DG, Bossuyt P, et al. Reducing waste from incomplete or unusable reports of biomedical research. Lancet, 2014, 383(9913): 267-276.
|
12. |
辛沂青, 陈泽, 吴云云, 等. 针刺治疗干眼症随机对照试验的报告质量评价. 中国循证医学杂志, 2020, 20(10): 1199-1207.
|
13. |
Loannidis JP, Evans SJ, Gøtzsche PC, et al. Better reporting of harms in randomized trials: an extension of the CONSORT statement. Ann Intern Med, 2004, 141(10): 781-788.
|
14. |
卢存存, 张强, 雷超, 等. 使用队列和常规收集数据开展随机对照试验的报告清单(CONSORT-ROUTINE2021)解读. 中国循证医学杂志, 2022, 22(6): 731-738.
|
15. |
Zhang X, Liang F, Lau CT, et al. STandards for Reporting Interventions in Clinical Trials Of Tuina/Massage (STRICTOTM): extending the CONSORT statement. J Evid Based Med, 2023, 16(1): 68-81.
|
16. |
Mayo-Wilson E, Fusco N, Li T, et al. Harms are assessed inconsistently and reported inadequately part 1: systematic adverse events. J Clin Epidemiol, 2019, 113: 20-27.
|
17. |
胡瑞学, 梁宁, 柴倩云, 等. PRISMA危害报告清单: 改进系统综述中危害的报告(一). 中国药物警戒, 2018, 15(6): 377-384.
|
18. |
Qureshi R, Chen X, Goerg C, et al. Comparing the value of data visualization methods for communicating harms in clinical trials. Epidemiol Rev, 2022, 44(1): 55-66.
|
19. |
Phillips R, Hazell L, Sauzet O, et al. Analysis and reporting of adverse events in randomised controlled trials: a review. BMJ Open, 2019, 9(2): e024537.
|
20. |
Cornelius V, Cro S, Phillips R. Advantages of visualisations to evaluate and communicate adverse event information in randomised controlled trials. Trials, 2020, 21(1): 1028.
|
21. |
Phillips R, Cro S, Wheeler G, et al. Visualising harms in publications of randomised controlled trials: consensus and recommendations. BMJ, 2022, 377: e068983.
|
22. |
Phillips R, Sauzet O, Cornelius V. Statistical methods for the analysis of adverse event data in randomised controlled trials: a scoping review and taxonomy. BMC Med Res Methodol, 2020, 20(1): 288.
|
23. |
Duan R, Tong J, Sutton AJ, et al. Origami plot: a novel multivariate data visualization tool that improves radar chart. J Clin Epidemiol, 2023, 156: 85-94.
|
24. |
Spicer JO, Coleman CG. Creating effective infographics and visual abstracts to disseminate research and facilitate medical education on social media. Clin Infect Dis, 2022, 74(Suppl 3): 14-22.
|
25. |
Guidolin K, Lin J, Zorigtbaatar A, et al. Evaluating the accuracy and design of visual abstracts in academic surgical journals. Ann Surg, 2022, 276(5): 275-283.
|